. 2019 Apr;22(4):384–390. doi: 10.22038/ijbms.2019.31788.7651

Table 2.

General characteristics of rats in all study groups

	Control (n = 8)	Diab (n = 8)	EMP (n = 8)
Body weight, g	343.25± 11.05	298 ± 8.33^a	291 ± 10.88
Serum glucose, mg/dL	82.87 ± 3.31	435.57 ± 66.56^a	205± 47.53^a,^b
HbA1c, %	5.5 ± 0.45	9.6 ± 0.86^a	6.4 ± 0.71^a,^b
Serum urea, mg/dL	32.81 ± 7.1	57.39 ± 10.48^a	42.11 ± 9.57^a,^b
Serum creatinine, mg/dL	0.67 ± 0.02	1.01 ± 0.05^a	0.83 ± 0.01^a,^b

Control, healthy control rats; Diab, diabetic control rats; EMP, diabetic rats treated with empagliflozin. Values are presented as mean ± S.D. HbA1c, hemoglobin A1c.

: P<0.01 vs Control rats

: P<0.01 vs Diab rats